{"id":6464,"date":"2025-07-03T15:27:12","date_gmt":"2025-07-03T15:27:12","guid":{"rendered":"https:\/\/www.angelssante.fr\/?p=6464"},"modified":"2025-09-01T15:05:51","modified_gmt":"2025-09-01T15:05:51","slug":"angels-sante-warmly-welcomes-inits","status":"publish","type":"post","link":"https:\/\/www.angelssante.fr\/en\/angels-sante-warmly-welcomes-inits\/","title":{"rendered":"Angels Sant\u00e9 warmly welcomes INITS"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"6464\" class=\"elementor elementor-6464\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c7bb6a1 e-flex e-con-boxed e-con e-parent\" data-id=\"c7bb6a1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f50fb21 elementor-widget elementor-widget-heading\" data-id=\"f50fb21\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Angels Sant\u00e9 warmly welcomes INITS as a new corporate member<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54baaec elementor-widget elementor-widget-text-editor\" data-id=\"54baaec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>We are thrilled to announce that\u00a0\u00a0<a class=\"wsMvqdsCQwHMdXuvCLlSAkmVYButhGSUc\" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/inits-group\/\" target=\"_self\" data-test-app-aware-link=\"\">INITS<\/a> has joined our network as a Corporate Member. This strategic collaboration strengthens our biotech ecosystem and brings valuable expertise.<\/p>\n<p>\ud83d\udd2c\u00a0What <a class=\"wsMvqdsCQwHMdXuvCLlSAkmVYButhGSUc\" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/inits-group\/\" target=\"_self\" data-test-app-aware-link=\"\">INITS <\/a>brings to our network:<br \/>&#8211; Over 10 years of expertise in pharmaceutical development<br \/>&#8211; End-to-end support: CMC, Regulatory Strategy, Clinical Supply, Quality Assurance<br \/>&#8211; Disruptive SMO (Shared Manufacturing Organization) concept &#8211; a shared bioproduction facility operational by Q2 2026. A unique opportunity for biotechs to manufacture their drug substances in a fully supervised environment.<\/p>\n<p>This alliance perfectly illustrates our mission: supporting healthcare innovation by connecting expertise and facilitating access to resources for our startups.<\/p>\n<p>Welcome to the Angels Sant\u00e9 family, <a class=\"wsMvqdsCQwHMdXuvCLlSAkmVYButhGSUc\" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/inits-group\/\" target=\"_self\" data-test-app-aware-link=\"\">INITS<\/a>!\u00a0 \ud83e\udd1d<br \/><br \/><\/p>\n<p>More about Inits : <a class=\"wsMvqdsCQwHMdXuvCLlSAkmVYButhGSUc\" tabindex=\"0\" href=\"https:\/\/inits.fr\/\" target=\"_self\" data-test-app-aware-link=\"\">https:\/\/inits.fr\/<\/a><br \/>More about Angels Sant\u00e9 : <a class=\"wsMvqdsCQwHMdXuvCLlSAkmVYButhGSUc\" tabindex=\"0\" href=\"https:\/\/lnkd.in\/gWwmJTFk\" target=\"_self\" data-test-app-aware-link=\"\">https:\/\/lnkd.in\/gWwmJTFk<\/a><br \/>Full details in our press release \ud83d\udc47<\/p>\n<p>Angels Sant\u00e9\u00a0: <a class=\"iDnVmHHNAJlvEVnDtbeuHZogHkrorPrZNxnz\" tabindex=\"0\" href=\"http:\/\/www.angelssante.fr\/en\/\" target=\"_self\" data-test-app-aware-link=\"\">www.angelssante.fr<\/a>\u00a0<\/p>\n<p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-82b81b2 e-flex e-con-boxed e-con e-parent\" data-id=\"82b81b2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-62358ed elementor-widget elementor-widget-ucaddon_newsletter_iframe\" data-id=\"62358ed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"ucaddon_newsletter_iframe.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\n<!-- start Newsletter iFrame -->\n\n<div class=\"mahii-iframe\"><iframe src=\"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/FINAL-CP-INITS_EN_INITS.pdf\"><\/iframe><\/div>\n<!-- end Newsletter iFrame -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Angels Sant\u00e9 is thrilled to welcome INITS as a new corporate member <\/p>","protected":false},"author":2,"featured_media":6467,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22,8],"tags":[],"class_list":["post-6464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mise-en-avant","category-nos-communiques-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Angels Sant\u00e9 warmly welcomes INITS - Angels Sante<\/title>\n<meta name=\"description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.angelssante.fr\/en\/angels-sante-warmly-welcomes-inits\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 warmly welcomes INITS - Angels Sante\" \/>\n<meta property=\"og:description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.angelssante.fr\/en\/angels-sante-warmly-welcomes-inits\/\" \/>\n<meta property=\"og:site_name\" content=\"Angels Sante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-03T15:27:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-01T15:05:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"755\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"caroline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"caroline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/\"},\"author\":{\"name\":\"caroline\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\"},\"headline\":\"Angels Sant\u00e9 warmly welcomes INITS\",\"datePublished\":\"2025-07-03T15:27:12+00:00\",\"dateModified\":\"2025-09-01T15:05:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/\"},\"wordCount\":157,\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/6-2.png\",\"articleSection\":[\"Mise en avant\",\"Nos communiqu\u00e9s de presse\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/\",\"name\":\"Angels Sant\u00e9 warmly welcomes INITS - Angels Sante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/6-2.png\",\"datePublished\":\"2025-07-03T15:27:12+00:00\",\"dateModified\":\"2025-09-01T15:05:51+00:00\",\"description\":\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/6-2.png\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/6-2.png\",\"width\":2000,\"height\":755},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-warmly-welcomes-inits\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.angelssante.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 warmly welcomes INITS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"name\":\"Angel Sante\",\"description\":\"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.angelssante.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\",\"name\":\"Angel Sante\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"width\":685,\"height\":290,\"caption\":\"Angel Sante\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/angelssante\\\/?viewAsMember=true\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\",\"name\":\"caroline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"caption\":\"caroline\"},\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/en\\\/author\\\/caroline\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 warmly welcomes INITS - Angels Sante","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.angelssante.fr\/en\/angels-sante-warmly-welcomes-inits\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 warmly welcomes INITS - Angels Sante","og_description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","og_url":"https:\/\/www.angelssante.fr\/en\/angels-sante-warmly-welcomes-inits\/","og_site_name":"Angels Sante","article_publisher":"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true","article_published_time":"2025-07-03T15:27:12+00:00","article_modified_time":"2025-09-01T15:05:51+00:00","og_image":[{"width":2000,"height":755,"url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png","type":"image\/png"}],"author":"caroline","twitter_card":"summary_large_image","twitter_misc":{"Written by":"caroline","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#article","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/"},"author":{"name":"caroline","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e"},"headline":"Angels Sant\u00e9 warmly welcomes INITS","datePublished":"2025-07-03T15:27:12+00:00","dateModified":"2025-09-01T15:05:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/"},"wordCount":157,"publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png","articleSection":["Mise en avant","Nos communiqu\u00e9s de presse"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/","url":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/","name":"Angels Sant\u00e9 warmly welcomes INITS - Angels Sante","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#primaryimage"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png","datePublished":"2025-07-03T15:27:12+00:00","dateModified":"2025-09-01T15:05:51+00:00","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","breadcrumb":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#primaryimage","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/07\/6-2.png","width":2000,"height":755},{"@type":"BreadcrumbList","@id":"https:\/\/www.angelssante.fr\/angels-sante-warmly-welcomes-inits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.angelssante.fr\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 warmly welcomes INITS"}]},{"@type":"WebSite","@id":"https:\/\/www.angelssante.fr\/#website","url":"https:\/\/www.angelssante.fr\/","name":"Angel Sante","description":"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.","publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.angelssante.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.angelssante.fr\/#organization","name":"Angel Sante","url":"https:\/\/www.angelssante.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","width":685,"height":290,"caption":"Angel Sante"},"image":{"@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true"]},{"@type":"Person","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e","name":"caroline","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","caption":"caroline"},"url":"https:\/\/www.angelssante.fr\/en\/author\/caroline\/"}]}},"_links":{"self":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/comments?post=6464"}],"version-history":[{"count":7,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6464\/revisions"}],"predecessor-version":[{"id":6473,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6464\/revisions\/6473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media\/6467"}],"wp:attachment":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media?parent=6464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/categories?post=6464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/tags?post=6464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}